Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4-month, Open-label, Multi-center Study to Explore Tolerability and Safety and Health Outcomes of FTY720 in Patients With Relapsing Forms of Multiple Sclerosis

NCT01127750 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01127750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01127750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4-month, Open-label, Multi-center Study to Explore Tolerability and Safety and Health Outcomes of FTY720 in Patients With Relapsing Forms of Multiple Sclerosis
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2010
Completion date
October 31, 2011
Enrollment
2,417 (actual)
Sites
289

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing multiple sclerosis